Immunomodulatory effects of tyrosine kinase inhibitors (TKIs) in renal cell carcinoma (RCC) patients.Marianna Nuti, Paolo Marchetti, Chiara Napoletano et al.|Journal of Clinical Oncology|2017Cited by 5